How one company is getting out front of flu mutations in both humans and livestock.
Brian Brandt, head of Pirenzia, Inc., is leading an effort to employ DNA shuffling to develop a vaccine designed to trigger an antibody response to flu viruses without the need to be incubated in an egg solution. It is a technique with no corollary in modern vaccines, and it’s applicable across multiple H1N1 strains.